Naoya Nakamura

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

Mamiko Sakata‐Yanagimoto, Terukazu Enami, Kenichi Yoshida et al. · Nature Genetics · 2014 · 642 citations

Medicine, Cancer Biology, Oncology +14

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

Takashi Oyama, Kazuhito Yamamoto, Naoko Asano et al. · Clinical Cancer Research · 2007 · 459 citations

Medicine, Hematology, Pathology +15

Clinicopathologic analysis of <scp>TAFRO</scp> syndrome demonstrates a distinct subtype of <scp>HHV</scp>‐8‐negative multicentric Castleman disease

Noriko Iwaki, David C. Fajgenbaum, Christopher S. Nabel et al. · American Journal of Hematology · 2015 · 285 citations · Full text

Medicine, Immunology, Pathology +10

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

Naoto Tomita, Mayumi Tokunaka, Naoya Nakamura et al. · Haematologica · 2009 · 205 citations · Full text

Medicine, Oncology, Pathology +16

Castleman-Kojima Disease (TAFRO Syndrome) : A Novel Systemic Inflammatory Disease Characterized by a Constellation of Symptoms, Namely, Thrombocytopenia, Ascites (Anasarca), Microcytic Anemia, Myelofibrosis, Renal Dysfunction, and Organomegaly : A Status Report and Summary of Fukushima (6 June, 2012) and Nagoya Meetings (22 September, 2012)

Hiroshi Kawabata, Kazue Takai, Masaru Kojima et al. · Journal of Clinical and Experimental Hematopathology · 2013 · 187 citations · Full text

Medicine, Hematology, Pathology +9